Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2015-03-16 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is clearly identified by the header 'RNS Number : 5075H' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', which involves reporting changes or clarifications regarding significant shareholdings (crossing the 5% threshold) by an asset manager on behalf of clients. This type of mandatory disclosure regarding major share ownership changes fits the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific nature of the content points directly to MRQ rather than the general fallback RNS category.
2015-03-16 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1896 characters) and is explicitly marked with an 'RNS Number'. The content details the total number of issued ordinary shares with voting rights (87,951,052) as of the announcement date (27 February 2015), referencing compliance with DTR 5.6.1R (Disclosure and Transparency Rules). This type of notification regarding the total voting rights denominator is a standard regulatory disclosure, often falling under general regulatory announcements or specific share/capital change notifications. Since it is a direct notification to the market via RNS about the share capital structure for voting purposes, it aligns closely with either 'Major Shareholding Notification' (MRQ) if it were about a shareholder crossing a threshold, or more generally, a regulatory filing. However, the core information is the total share count for voting rights calculation, which is a specific regulatory disclosure. Given the options, 'Major Shareholding Notification' (MRQ) is often used for changes in significant ownership, but this is a statement of the total capital base. Since it is a direct regulatory announcement provided via RNS, and doesn't fit perfectly into the other specific categories like DIV, CAP, or SHA (which usually involve issuance/buybacks), the most appropriate general regulatory category is RNS, or potentially SHA if interpreted as a capital structure update. Because it is explicitly labeled as an RNS notification and provides the denominator for DTR calculations, RNS is the safest classification for a general regulatory update that isn't a full report or a specific transaction announcement. However, looking closely at the definitions, 'Major Shareholding Notification' (MRQ) is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. While this document states the total, it serves the same regulatory purpose as the denominator used in those notifications. Given the context of DTR compliance and share capital notification, and the explicit RNS header, RNS is the best fit as a general regulatory filing.
2015-02-27 English
Half Yearly Financial Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Yearly Financial Report 2015' for Dechra Pharmaceuticals PLC, covering the six months ended 31 December 2014. It contains detailed financial statements, revenue breakdowns, operational reviews, and management commentary. It is a comprehensive interim report rather than a mere announcement or summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2015
2015-02-23 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1894 characters) and is explicitly marked with an 'RNS Number' and states, 'In conformity with DTR 5.6.1R, the Company notifies the market of the following:'. It details the total number of issued shares with voting rights (87,947,167) as of the announcement date (30 January 2015). This type of notification regarding the total voting rights denominator is a standard regulatory disclosure, often disseminated via the Regulatory News Service (RNS). While it relates to share capital, it is not a formal share issue/change announcement (SHA) or a transaction in own shares (POS), but rather a mandatory periodic disclosure about the total number of shares eligible to vote. Given the RNS header and the nature of the disclosure (total voting rights), the most appropriate classification is RNS, which serves as the general regulatory announcement category.
2015-01-30 English
Trading Update and Notice of HY results
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and the concluding statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content is a 'Trading Update' providing unaudited highlights for the half-year period ended 31 December 2014, ahead of the full results announcement on February 23, 2015. This is a brief, periodic announcement of financial performance highlights, not the comprehensive report itself (which would be an IR or 10-K). Since it is a periodic financial update announcement, it fits best under 'Earnings Release' (ER) as it provides key financial highlights for a period. It is not a full transcript (CT), a formal annual report (10-K), or a general regulatory filing (RNS) when a more specific category like ER applies. H1 2015
2015-01-14 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1898 characters) and is explicitly marked with an 'RNS Number' and states that the information is provided by 'RNS The company news service from the London Stock Exchange'. The content details the total number of issued shares with voting rights as of the announcement date (31 December 2014), which is information relevant for shareholders determining their notification obligations under Disclosure and Transparency Rules (DTR 5.6.1R). This type of mandatory, short-form regulatory update that doesn't fit a specific financial report category (like 10-K or IR) is best classified as a general Regulatory Filing (RNS). It is not a Major Shareholding Notification (MRQ) as it is the company reporting its total outstanding shares, not an investor reporting a change in their holding, nor is it a Share Issue/Capital Change (SHA) which usually implies an action taken, but rather a disclosure of the current state for regulatory compliance.
2014-12-31 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.